https://www.zonebourse.com/cours/action/SANOFI-4698/actualite/Covid-Sanofi-et-GSK-poursuivront-l-essai-de-phase-3-sur-leur-vaccin-jusqu-au-T1-2022-37324883/?utm_source=telegram&utm_medium=social&utm_campaign=share